Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Brian Skorney is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/29/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/29/2024 | BIIB | Buy Now | Biogen | $210.66 | 39.56% | $316 → $294 | Maintains | Outperform | Get Alert |
| 06/21/2024 | SRPT | Buy Now | Sarepta Therapeutics | $146.30 | 36.71% | $170 → $200 | Maintains | Outperform | Get Alert |
| 06/20/2024 | GILD | Buy Now | Gilead Sciences | $77.30 | 3.49% | $80 → $80 | Maintains | Neutral | Get Alert |
| 06/17/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $43.00 | -9.3% | $34 → $39 | Maintains | Outperform | Get Alert |
| 06/13/2024 | LXEO | Buy Now | Lexeo Therapeutics | $11.50 | 143.48% | → $28 | Initiates | → Outperform | Get Alert |
| 05/23/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.36 | 14.05% | $52 → $62 | Maintains | Outperform | Get Alert |
| 05/10/2024 | SLNO | Buy Now | Soleno Therapeutics | $48.48 | 48.51% | → $72 | Initiates | → Outperform | Get Alert |
| 04/16/2024 | MRNS | Buy Now | Marinus Pharma | $1.45 | 38.26% | $20 → $2 | Downgrade | Outperform → Neutral | Get Alert |
| 03/06/2024 | RGNX | Buy Now | Regenxbio | $15.38 | 153.58% | $34 → $39 | Maintains | Outperform | Get Alert |
| 02/29/2024 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.36 | -4.34% | $45 → $52 | Maintains | Outperform | Get Alert |
| 02/27/2024 | ANRO | Buy Now | Alto Neuroscience | $14.36 | 122.84% | → $32 | Initiates | → Outperform | Get Alert |
| 02/14/2024 | BIIB | Buy Now | Biogen | $210.66 | 50% | $333 → $316 | Maintains | Outperform | Get Alert |
| 12/08/2023 | BHVN | Buy Now | Biohaven | $40.15 | 44.45% | → $58 | Initiates | → Outperform | Get Alert |
| 12/08/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $43.50 | 44.83% | → $63 | Initiates | → Outperform | Get Alert |
| 09/11/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.36 | -17.22% | $43 → $45 | Maintains | Outperform | Get Alert |
| 08/11/2023 | MRNS | Buy Now | Marinus Pharma | $1.45 | 1282.55% | $24 → $20 | Maintains | Outperform | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $146.80 | 0.82% | $140 → $148 | Maintains | Outperform | Get Alert |
| 07/31/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $85 → $173 | Maintains | Outperform | Get Alert |
| 06/30/2023 | EIGR | Buy Now | Eiger BioPharmaceuticals | — | — | $90 → $150 | Maintains | Outperform | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -29.54% | $800 → $760 | Maintains | Neutral | Get Alert |
| 06/20/2023 | RGNX | Buy Now | Regenxbio | $15.38 | 173.08% | → $42 | Initiates | → Outperform | Get Alert |
| 06/07/2023 | BIIB | Buy Now | Biogen | $210.66 | 61.4% | → $340 | Reiterates | Outperform → Outperform | Get Alert |
| 06/02/2023 | RGNX | Buy Now | Regenxbio | $15.38 | 173.08% | → $42 | Initiates | → Outperform | Get Alert |
| 05/22/2023 | ICPT | Buy Now | Intercept Pharma | — | — | $35 → $18 | Maintains | Outperform | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -34.34% | $280 → $325 | Maintains | Neutral | Get Alert |
| 04/25/2023 | APLT | Buy Now | Applied Therapeutics | $5.22 | 168.2% | $18 → $14 | Maintains | Outperform | Get Alert |
| 03/30/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $54.36 | -11.7% | → $48 | Initiates | → Outperform | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -25.83% | $756 → $800 | Maintains | Neutral | Get Alert |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $146.30 | 38.07% | $152 → $202 | Maintains | Outperform | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $40 → $85 | Maintains | Neutral | Get Alert |
| 02/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -29.91% | $670 → $756 | Maintains | Neutral | Get Alert |
| 11/09/2022 | MRNS | Buy Now | Marinus Pharma | $1.45 | 1559.06% | $32 → $24 | Maintains | Outperform | Get Alert |
| 10/31/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -43.43% | → $280 | Maintains | Neutral | Get Alert |
| 10/24/2022 | MYOV | Buy Now | Myovant Sciences | — | — | $20 → $27 | Downgrade | Outperform → Neutral | Get Alert |
| 10/12/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $43 → $55 | Maintains | Outperform | Get Alert |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | $52 → $35 | Maintains | Outperform | Get Alert |
| 09/28/2022 | BIIB | Buy Now | Biogen | $210.66 | 61.4% | $224 → $340 | Upgrade | Neutral → Outperform | Get Alert |
| 08/16/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $66 → $40 | Maintains | Outperform | Get Alert |
| 08/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $37 → $27 | Maintains | Neutral | Get Alert |
| 08/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -49.49% | $250 → $250 | Maintains | Neutral | Get Alert |
| 07/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -49.49% | → $250 | Maintains | Neutral | Get Alert |
| 05/19/2022 | ENTA | Buy Now | Enanta Pharma | $15.80 | 469.62% | $130 → $90 | Maintains | Outperform | Get Alert |
| 05/17/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $72 → $66 | Maintains | Outperform | Get Alert |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | — | — | Downgrade | Outperform → Neutral | Get Alert |
| 03/23/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -51.52% | $240 → $240 | Maintains | Outperform | Get Alert |
| 01/30/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -51.52% | $240 → $240 | Maintains | Outperform | Get Alert |
| 01/27/2022 | RPHM | Buy Now | Reneo Pharmaceuticals | $1.50 | 1766.67% | → $28 | Initiates | → Outperform | Get Alert |
| 12/21/2021 | BIIB | Buy Now | Biogen | $210.66 | 22.47% | $296 → $258 | Maintains | Neutral | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | — | Downgrade | Outperform → Neutral | Get Alert |
| 12/02/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -51.52% | $240 → $240 | Maintains | Outperform | Get Alert |
| 10/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -51.52% | $240 → $240 | Maintains | Outperform | Get Alert |
| 08/01/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -51.52% | $240 → $240 | Maintains | Outperform | Get Alert |
| 04/20/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $495.00 | -49.09% | $252 → $252 | Maintains | Outperform | Get Alert |
